University of Pittsburgh
CMS Contractors Novitas, FCSO Finalize Non-Coverage Decisions for Certain Cancer Genetic Tests
Tests from Castle Biosciences, Pacific Edge Diagnostics, Interpace Biosciences, Clinical Genomics, and the University of Pittsburgh Medical Center will no longer be covered.
Metastatic Eye Cancer Immunogenomics Study Leads to Predictors of Immunotherapy Response
Researchers came up with a gene expression score for metastatic uveal melanoma cases that appeared to predict response to adoptive tumor infiltrating lymphocyte therapy.
Researchers at the University of Pittsburgh described their real-time whole-genome sequencing surveillance workflow as well as its associated costs in a preprint last month.
At the 2023 NSGC annual conference in Chicago, genetic counselors weighed how best to integrate their services into primary care.
CMS Contractor Novitas Rescinds Coverage for Multiple Cancer Genetic Tests
Novitas reviewed, analyzed, and published literature for a variety of genetic oncology tests and highlighted several that it claims are not medically reasonable or necessary.